Inhibition of adenosine monophosphate-activated protein kinase induces apoptosis in multiple myeloma cells
- 1 April 2007
- journal article
- Published by Wolters Kluwer Health in Anti-Cancer Drugs
- Vol. 18 (4) , 405-410
- https://doi.org/10.1097/cad.0b013e32801416b6
Abstract
In this study, we show that adenosine monophosphate-activated protein kinase (AMPK) is expressed and activated in multiple myeloma cells. The inhibition of AMPK induced growth arrest and reduction of cell viability in the cell viability assay using the water-soluble tetrazolium salt 4-[3-(4-iodophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-1,3-benzene disulfonate (WST-1 assay). Induction of apoptosis was determined by annexin-V and propidium iodide staining. The prevention of apoptosis using the pancaspase inhibitor ZVAD-fmk and caspase-3 cleavage upon incubation with the AMPK inhibitor (AMPKI) is shown. Furthermore, incubation of myeloma cells with AMPKI resulted in the downregulation of pAMPK, Mcl-1 and Bcl-xL. Coincubation of AMPKI and melphalan led to a strong additional increase of apoptosis in myeloma cells. We conclude that AMPKI has a strong antimyeloma activity in vitro and represents a new targeted strategy in the treatment of multiple myeloma.Keywords
This publication has 18 references indexed in Scilit:
- AMPK: A Key Sensor of Fuel and Energy Status in Skeletal MusclePhysiology, 2006
- 5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside Inhibits Cancer Cell Proliferation in Vitro and in Vivo via AMP-activated Protein KinaseJournal of Biological Chemistry, 2005
- AMPK, the metabolic syndrome and cancerTrends in Pharmacological Sciences, 2005
- The AMP-activated protein kinase pathway – new players upstream and downstreamJournal of Cell Science, 2004
- The AMP-activated protein kinase cascade – a unifying system for energy controlTrends in Biochemical Sciences, 2004
- Acadesine activates AMPK and induces apoptosis in B-cell chronic lymphocytic leukemia cells but not in T lymphocytesBlood, 2003
- Chemosensitization of myeloma plasma cells by an antisense-mediated downregulation of Bcl-2 proteinLeukemia, 2003
- Cell Cycle Regulation via p53 Phosphorylation by a 5′-AMP Activated Protein Kinase Activator, 5-Aminoimidazole- 4-Carboxamide-1-β- -Ribofuranoside, in a Human Hepatocellular Carcinoma Cell LineBiochemical and Biophysical Research Communications, 2001
- Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials. Myeloma Trialists' Collaborative Group.Journal of Clinical Oncology, 1998
- Combination chemotherapy versus melphalan and prednisolone in the treatment of multiple myeloma: an overview of published trials.Journal of Clinical Oncology, 1992